In vivo nitrate tolerance is not associated with reduced bioconversion of nitroglycerin to nitric oxide

Circulation

Volumn 94, Issue 9, 1996, Pages 2241-2247

  Laursen, Jørn Bech ^b   Mülsch, Alexander ^a   Boesgaard, Søren ^b   Mordvintcev, Petr ^b   Trautner, Simon ^b   Gruhn, Nicolai ^b   Nielsen Kudsk, Jens Erik ^b   Busse, Rudi ^b   Aldershvile, Jan ^b  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^b NONE

Author keywords

arteries; endothelium derived factors; free radicals; nitroglycerin; veins

Indexed keywords

GLYCERYL TRINITRATE; NITRIC OXIDE;

ANIMAL EXPERIMENT; ARTICLE; BLOOD VESSEL TONE; DRUG DEGRADATION; DRUG EFFECT; DRUG TOLERANCE; FEMALE; HEMODYNAMICS; INTRAVENOUS DRUG ADMINISTRATION; NONHUMAN; PRIORITY JOURNAL; RAT; SMOOTH MUSCLE RELAXATION; VASCULAR SMOOTH MUSCLE; VASODILATATION;

EID: 0029827822     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.94.9.2241     Document Type: Article

References (25)

1. Ignarro LJ, Lippton H, Edwards JC, Baricos WH, Hyman AL, Kadowitz PJ, Gruetter CA. Mechanisms of vascular smooth muscle relaxation by organic nitrates, nitrites, nitroprusside and nitric oxide: evidence for the involvement of S-nitrosothiols as active intermediates. J Pharmacol Exp Ther. 1981;218:739-749.
2. Chung SJ, Fung HL. Relationship between nitroglycerin-induced vascular relaxation and nitric oxide production. Biochem Pharmacol. 1993;45:157-163.
3. Mülsch A, Mordvintcev P, Bassenge E, Jung F, Clement B, Busse R. In vivo spin trapping of glyceryl tri nitrate-derived nitric oxide in rabbit blood vessels and organs. Circulation. 1995;92:1876-1882.
4. Thadani U, Fung HL, Darke AC, Parker JO. Oral isosorbide dinitrate in angina pectoris: comparison of duration of action and dose-response relation during acute and sustained therapy. Am J Cardiol. 1982;49:411-419.
5. Zimrin D, Reichek N, Bogin KT, Aurigemma G, Douglas P, Berko B, Fung HL. Antianginal effects of intravenous nitroglycerin over 24 hours. Circulation. 1988;77:1376-1384.
6. Boesgaard S, Aldershvile J, Poulsen HE. Preventive administration of intravenous N-acetylcysteine and development of tolerance to isosorbide dinitrate in patients with angina pectoris. Circulation. 1992;85:143-149.
7. Packer M, Lee WH, Kessler PD, Gottlieb SS, Medina N, Yushak M. Prevention and reversal of nitrate tolerance in patients with congestive heart failure. N Engl J Med. 1987;317:799-804.
8. Parker JD, Farrell B, Fenton T, Cohanim M, Parker JO. Counter-regulatory responses to continuous and intermittent therapy with nitroglycerin. Circulation. 1991;84:2336-2345.
9. Münzel T, Sayegh H, Harrison DG. Nitroglycerin tolerance is associated with increases in vascular constriction mediated by protein kinase C. Circulation. 1994;90(suppl I):I-321. Abstract.
10. Münzel T, Sayegh H, Freeman BA, Tarpey M, Harrison DG. Evidence for enhanced vascular Superoxide anion production in nitrate tolerance. J Clin Invest. 1995;95:187-194.
11. Slack CJ, McLaughlin BE, Nakatsu K, Marks GS, Brien JF. Nitric oxide-induced vasodilation of organic nitrate-tolerant rabbit aorta. Can J Physiol Pharmacol 1988;66:1344-1346.
12. Förster S, Woditsch I, Schröder H, Schrör K. Reduced nitric oxide release causes nitrate tolerance in the intact coronary circulation. J Cardiovasc Pharmacol. 1991;17:867-872.
13. Salvemini D, Pistelli A, Vane J. Conversion of glycerol trinitrate to nitric oxide in tolerant and non-tolerant smooth muscle and endothelial cells. Br J Pharmacol 1993;108:162-169.
14. Boesgaard S, Aldershvile J, Poulsen HE, Loft S, Anderson ME, Meister A. Nitrate tolerance in vivo is not associated with depletion of arterial or venous thiol levels. Circ Res. 1994;74:115-120.
15. Münzel T, Kurz S, Tarpey M, Freeman BA, Harrison DG. Similarities and discrepancies between in vivo and in vitro nitrate tolerance. Circulation. 1995;92(suppl I):I-4. Abstract.
16. Mülsch A, Busse R, Winter I, Bassenge E. Endothelium- and sydnonimine dependent responses of native and cultured aortic smooth muscle cells are not impaired by nitroglycerin tolerance. Naunyn Schmiedebergs Arch Pharmacol. 1989;339:568-574.
17. Boesgaard S, Petersen JS, Aldershvile J, Poulsen HE, Flachs H. Nitrate tolerance: effect of thiol supplementation during prolonged nitroglycerin infusion in an in vivo rat model. J Pharmacol Exp Ther. 1991;258:851-856.
18. Mülsch A, Bara A, Mordvintcev P, Vanin A, Busse R. Specificity of different organic nitrates to elicit NO formation in rabbit vascular tissues and organs in vivo. Br J Pharmacol. 1995;116:2743-2749.
19. O'Keefe DH, Erbel RE, Peterson JA. Studies of the oxygen binding site of cytochrome P-450. J Biol Chem. 1978;253:3509-3516.
20. Hille R, Olson JS, Palmer G. Spectral transitions of nitrosyl hemes during ligand binding to hemoglobin. J Biol Chem. 1979;254:12110-12120.
21. Nielsen-Kudsk F, Poulsen B, Ryom C, Nielsen-Kudsk JE. A strain- gauge myograph for isometric measurements of tension in isolated small blood vessels and other muscle preparations. J Pharmacol Methods. 1986;16:215-225.
22. Kurz S, Münzel T, Harrison DG. A role of angiotensin II in nitrate tolerance. Endothelium. 1995;3(suppl):283. Abstract.
23. Mülsch A, Mordvintcev P, Vanin A. Quantification of nitric oxide in biological samples by electron spin resonance spectroscopy Neuroprotocols. 1992;1:165-173.
24. Kuropteva TV, Pastushenko ON. Change in paramagnetic blood and liver complexes in animals under the influence of nitroglycerin. Dokl Acad Nauk SSSR. 1985;281:189-192.
25. Vanin A, Mordvintcev P, Kleshchev AL. Appearance of nitrogen oxide in animal tissues in vivo. Stud Biophys. 1984;102:135-143.